[Federal Register Volume 76, Number 70 (Tuesday, April 12, 2011)]
[Notices]
[Pages 20352-20353]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-8653]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Intent To Award Affordable Care Act (ACA) Funding

    Notice of Intent to award Affordable Care Act (ACA) funding to two 
Emerging Infections Program (EIP) grantees, the Connecticut Department 
of Public Health and the Georgia Department of Community Health, to 
increase support for vaccine effectiveness activities for rotavirus 
vaccine and pneumococcal conjugate vaccine. These activities were 
proposed in the grantees' Fiscal Year (FY) 2011 non-competitive 
continuation applications under funding opportunity CI05-026, 
``Emerging Infections Program (EIP).''
AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice provides public announcement of CDC's intent to 
award Affordable Care Act (ACA) appropriations to the Connecticut 
Department of Public Health and the Georgia Department of Community 
Health to conduct vaccine effectiveness activities for rotavirus 
vaccine and 13-valent pneumococcal conjugate vaccine (PCV). These 
activities were requested by the two grantees in their FY 2011 non-
competitive continuation applications submitted under funding 
opportunity CI05-026, ``Emerging Infections Program (EIP),'' Catalogue 
of Federal Domestic Assistance Number (CFDA): 93.283. Due to a lack of 
funding availability, these activities were either approved but 
unfunded or only partially funded in the grantee's FY 2011 continuation 
award.
    Only these two EIP sites requested funding for the rotavirus 
activities and only one site (Georgia) requested funding for the PCV 
activities. Since no other EIP sites requested funding for these 
specific activities, Connecticut and Georgia will be the only sites 
receiving funding for these activities.
    Approximately $433,500 in ACA funding will be awarded, which 
includes $333,500 for Rotavirus and $100,000 for PCV, to increase the 
amount of funding available to evaluate the effectiveness of new 
rotavirus and PCV vaccines currently being monitored through the 
aforementioned participating EIP sites. Funding is appropriated under 
the Affordable Care Act (PL 111-148), Title IV, Section 4002 
(Prevention and Public Health Fund).
    Accordingly, CDC adds the following information to the previously 
published funding opportunity announcement:

--Authority: Affordable Care Act (Pub. L. 111-148), Title IV, Section 
4002 (Prevention and Public Health Fund).
--CFDA #: 93.521--CDC--Investigations, Technical Assistance and 
Affordable Care Act Projects.

    Award Information:
    Type of Award: Supplement to existing cooperative agreement.

Approximate Total Current Fiscal Year ACA Funding: $433,500.
    Rotavirus (CT & GA): $333,500.
    PCV (GA only): $100,000.

    Anticipated Number of Awards: 2.
    Fiscal Year Funds: 2011.
    Anticipated Award Date: June 2011.
    Application Selection Process:
    Funding will be awarded to only those sites that included proposals 
for the specific rotavirus and PCV vaccine effectiveness activities in 
their EIP FY 2011 continuation application.
    Funding Authority:
    CDC will add the ACA Authority to that which is reflected in the 
published Funding Opportunity CDC-RFA-CI05-026. The revised funding 
authority language will read:

--This program is authorized under the Public Health Service Act 
Sections 301(a)[42 U.S.C. 241(a)], 317(k)(1)[42 U.S.C. 247b(k)(1)], and 
317(k)(2)[42 U.S.C. 247b(k)(2)], as amended, and Affordable Care Act 
(Pub. L. 111-148), Title IV, Section 4002 (Prevention and Public Health 
Fund).

DATES: The effective date for this action is the date of publication of 
this Notice and remains in effect until the expiration of the project 
period of the ACA funded applications.

FOR FURTHER INFORMATION CONTACT: Elmira Benson, Acting Deputy Director, 
Centers for Disease Control and Prevention, 2920 Brandywine Road, 
Atlanta, GA 30341, telephone (770) 488-2802, e-mail 
<a href="/cdn-cgi/l/email-protection#9bdef7f6f2e9fab5d9fef5e8f4f5dbf8fff8b5fcf4ed"><span class="__cf_email__" data-cfemail="c184adaca8b3a0ef83a4afb2aeaf81a2a5a2efa6aeb7">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: On March 23, 2010, the President signed into 
law the Affordable Care Act (ACA), Public Law 111-148. ACA is designed 
to improve and expand the scope of health care coverage for Americans. 
Cost savings through disease prevention is an

[[Page 20353]]

important element of this legislation and ACA has established a 
Prevention and Public Health Fund (PPHF) for this purpose. 
Specifically, the legislation states in Section 4002 that the PPHF is 
to ``provide for expanded and sustained national investment in 
prevention and public health programs to improve health and help 
restrain the rate of growth in private and public sector health care 
costs.'' ACA and the Prevention and Public Health Fund make improving 
public health a priority with investments to improve public health.
    The PPHF states that the Secretary shall transfer amounts in the 
Fund to accounts within the Department of Health and Human Services to 
increase funding, over the fiscal year 2008 level, for programs 
authorized by the Public Health Service Act, for prevention, wellness 
and public health activities including prevention research and health 
screenings, such as the Community Transformation Grant Program, the 
Education and Outreach Campaign for Preventative Benefits, and 
Immunization Programs.
    ACA legislation affords an important opportunity to advance public 
health across the lifespan and to reduce health disparities by 
supporting an intensive community approach to chronic disease 
prevention and control. Therefore, increasing funding available to 
applicants under this FOA using the PPHF to continue monitoring the 
effectiveness of vaccines is consistent with the purpose of the PPHF, 
as stated above, to provide for an expanded and sustained national 
investment in prevention and public health programs. Further, the 
Secretary allocated funds to CDC, pursuant to the PPHF, for the types 
of activities this FOA is designed to carry out.

    Dated: March 25, 2011.
Tanja Popovic,
Deputy Associate Director for Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2011-8653 Filed 4-11-11; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>